Treatment of chronic viral hepatitis

被引:23
作者
Main, J [1 ]
McCarron, B [1 ]
Thomas, HC [1 ]
机构
[1] St Marys Hosp, Imperial Coll Sch Med, London W2 1NY, England
关键词
hepatitis B; interferon; hepatitis C;
D O I
10.1177/095632029800900601
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
interferon-alpha therapy has proved effective for up to 40% of patients with adult-acquired chronic hepatitis B virus (HBV) infection and for 20-25% of those with chronic hepatitis C virus (HCV) infection. Nucleoside analogues, such as lamivudine and famciclovir, are showing promise as antiviral agents for chronic HBV and the combination of interferon-alpha and ribavirin is proving to be successful therapy for 40-50% of patients with chronic HCV. In this article we review current therapy and discuss future strategies of the therapy of chronic viral hepatitis.
引用
收藏
页码:449 / 460
页数:12
相关论文
共 112 条
[1]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[2]  
[Anonymous], 1997, HEPATOLOGY, V26, pS2
[3]   Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation [J].
Aye, TT ;
Bartholomeusz, A ;
Shaw, T ;
Bowden, S ;
Breschkin, A ;
McMillan, J ;
Angus, P ;
Locarnini, S .
JOURNAL OF HEPATOLOGY, 1997, 26 (05) :1148-1153
[4]   Molecular targets in inhibition of hepatitis C virus replication [J].
Bartenschlager, R .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04) :281-301
[5]   Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].
Bartholomew, MM ;
Jansen, RW ;
Jeffers, LJ ;
Reddy, KR ;
Johnson, LC ;
Bunzendahl, H ;
Condreay, LD ;
Tzakis, AG ;
Schiff, ER ;
Brown, NA .
LANCET, 1997, 349 (9044) :20-22
[6]  
BASSENDINE MF, 1981, GASTROENTEROLOGY, V80, P1016
[7]  
BELLOBUONO A, 1994, J HEPATOL S, V21, P35
[8]   Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C [J].
Bennett, WG ;
Inoue, Y ;
Beck, JR ;
Wong, JB ;
Pauker, SG ;
Davis, GL .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :855-+
[9]   Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [J].
Bizollon, T ;
Palazzo, U ;
Ducerf, C ;
Chevallier, M ;
Elliott, M ;
Baulieux, J ;
Pouyet, M ;
Trepo, C .
HEPATOLOGY, 1997, 26 (02) :500-504
[10]  
BLOOMER J, 1997, HPEATOLOGY, V25, pA1199